Non Invasive Ventilation on Peripheral Muscle Function and Aerobic Performance

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

January 24, 2018

Study Completion Date

February 28, 2018

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

Non-invasive ventilation bi-level

For the NIV intervention, two levels of positive airway pressure (bi-level) were used: the positive inspiratory airway pressure (IPAP) was fixed at 6 cmH2O (centimeters of water), which could be gradually increased up to 14 cmH2O (2 cmH2O every minute), depending on the patient's comfort. and gradually increased to 14 cmH2O (2 cmH2O every minute), While the expiratory airway pressure (EPAP) was set at 3 cmH2O, it could be gradually increased up to 7 cmH2O (1 cmH2O every minute), depending on the patient's comfort.while expiratory airway pressure (EPAP) was fixed at 3 cmH2O and gradually increased to 7 cmH2O (1 cmH2O every minute).

OTHER

Non-invasive ventilation placebo

The same pressure chosen by the subject during adaptation was used in the placebo intervention; however, a T tube was connected between the equipment and the circuit, creating a leak and leaving the circuit open. The tube characteristics were: 22 x 18 x 22 mm nebulizer T-connector.

Trial Locations (1)

59082-100

Federal University of Rio Grande do Norte, Natal

All Listed Sponsors
lead

Universidade Federal do Rio Grande do Norte

OTHER

NCT05417503 - Non Invasive Ventilation on Peripheral Muscle Function and Aerobic Performance | Biotech Hunter | Biotech Hunter